Doctors Test Bespoke Vaccine Against Ovarian CancerBy Jonas SchulzOctober 16, 2026 An early trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer patients.
